Results 121 to 130 of about 1,472,132 (249)

MicroRNA in localized scleroderma: a review of literature

open access: yesArchives of Dermatological Research, 2019
Localized scleroderma (LoSc) is rare connective tissue disease that manifests with inflammation and fibrosis of the skin. Depending on the LoSc subtype, adjacent structures such as subcutaneous tissue, fascia, muscles, bones may be affected. The hallmark
Katarzyna Wolska-Gawron   +2 more
semanticscholar   +1 more source

Recent Advances in Localized Scleroderma

open access: yesSclerosis
Localized scleroderma (LSc), or morphea, is an autoimmune connective tissue disease causing inflammation and fibrosis of the skin and underlying tissues. While distinct from systemic sclerosis, its clinical presentation is highly diverse.
Toshiya Takahashi   +2 more
doaj   +1 more source

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma

open access: yesPediatric Rheumatology Online Journal, 2018
Objectives To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by ...
Anna Agazzi   +4 more
doaj   +1 more source

Severe alopecia complicating systemic sclerosis [PDF]

open access: yes, 2015
Aims: To describe a case of systemic sclerosis (SSc) associated with severe alopecia areata (AA) responsive to topical and systemic treatments, including vasoactive and immunosuppressive drugs (mycophenolate mofetil). Presentation of the Case: A 56 year
Cassone, Giulia   +3 more
core   +1 more source

Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma

open access: yesJournal of Rheumatology, 2019
Objective. To perform a comparative effectiveness feasibility study in juvenile localized scleroderma (LS), using standardized treatment regimens (consensus treatment plans; CTP). Methods.
Suzanne C. Li   +14 more
semanticscholar   +1 more source

Parry-Romberg Syndrome Associated with Localized Scleroderma

open access: yesCase Reports in Neurology, 2010
Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is characterized by progressive facial hemiatrophy and frequently overlaps with a condition known as linear scleroderma ‘en coup de sabre’.
Jelena Maletic   +4 more
doaj   +1 more source

Juvenile localized scleroderma

open access: yesSri Lanka Journal of Child Health, 2019
No abstract available Sri Lanka Journal of Child Health, 2019; 48(4): 364 ...
Luis Zavaleta-Medina   +4 more
openaire   +2 more sources

A case of localized bullous scleroderma

open access: yesVestnik Dermatologii i Venerologii, 2017
Bullous scleroderma is a rare type of the focal form of the disease mainly affecting the skin and characterized by induration and sclerosis foci as well as subepidermal blisters containing a transparent matter.
A. L. Bakulev   +3 more
doaj   +1 more source

Сучасні аспекти патогенетичної терапії хворих на склеродермію. Огляд літератури [PDF]

open access: yes, 2015
Дані літератури свідчать, що традиційні лікарські препарати у хворих на склеродермію ефективні далеко не завжди; багато з них спричиняють різні побічні реакції, що обумовлює пошук принципово нових терапевтичних технологій, у тому числі – з використанням ...
Горбунцов, В.В.   +2 more
core  

Experience with Lipofilling in Children with Localized Scleroderma: Case Study

open access: yesВопросы современной педиатрии
Background. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues.
Alina R. Misbakhova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy